Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity

Microcirculation

Volumn 15, Issue 7, 2008, Pages 615-620

  Rosenson, Robert S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Aspirin; Blood viscosity; Cardiovascular disease; Dipyridamole; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEMATOCRIT; HUMAN; HYPERHOMOCYSTEINEMIA; LOW DRUG DOSE; PRIORITY JOURNAL; RISK ASSESSMENT; SHEAR RATE; TREATMENT DURATION; VISCOMETER;

ADULT; AGED; ASPIRIN; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; DIPYRIDAMOLE; FEMALE; HEMATOCRIT; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS;

EID: 57149120134     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680802229316     Document Type: Article

References (25)

1. Diener, HC, Cunha, L., Forbes, C., Sivenius, J., Smets, P. and Lwenthal, A. (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci, 143, pp. 1-13.
2. Halkes, PH, van Gijn, J., Kappelle, LJ, Koudstaal, PJ and Algra, A. (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomized, controlled trial. Lancet, 367, pp. 1665-1673.
3. Aarts, PA, Heethaar, RM and Sixma, JJ. (1984) Red blood cell deformability influences platelet-vessel wall interaction in flowing blood. Blood, 64, pp. 1228-1233.
4. Glaser, R. (1993) Mechanisms of electromechanical coupling in membranes demonstrated by transmembrane potential-dependent shape transformation of human erythrocytes. Bioelectrochem Bioenerg, 30, pp. 103-109.
5. Saniabadi, AR, Fisher, TC, Lau, CS, Bridges, A., Taylor, J., Belch, J. and Forbes, CD. (1992) Dipyridamole increases human red blood cell deformability. Eur J Clin Pharmacol, 42, pp. 651-654.
6. Bergfeld, GR and Forrester, T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res, 26, pp. 40-47.
7. Gresele, P., Amout, J., Teckmyn, H. and Vermylen, J. (1986) Mechanism of antiplatelet action of dipyridamole in whole blood: Modulation of adenosine concentration and activity. Thromb Haemost, 55, pp. 12-17.
8. Klabunde, RE. (1983) Effects of dipyridamole on postischemic vasodilatation and extracellular adenosine. Am J Physiol, 244, pp. 273-280.
9. Ferrandon, P., Barcelo, B. and Armstrong, JM. (1991) A comparison of the effects of ranolazine, lidoflazine and dipyridamole on the uptake and catabolism of adenosine in human red blood cells. Fundam Clin Pharmacol, 5, pp. 456-459.
10. Chakrabarti, S., Viseva, O., Iyu, D., Varghese, S. and Freedman, JE. (2005) The effect of dipyridamole on vascular cell-derived reactive oxygen species. J Pharmacol Exp Ther, 315, pp. 494-500.
11. Costello, PB and Green, FA. (1982) Aspirin survival in human blood modulated by the concentration of erythrocytes. Arthritis Rheum, 25, pp. 550-555.
12. Nappo, F., De Rosa, N., Marfella, R., De Lucia, D., Ingrosso, D., Perna, AF, Farzati, B. and Giugliano, D. (1999) Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA, 281, pp. 2113-2118.
13. Wang, S., Boss, AH, Kensey, KR and Rosenson, RS. (2003) Variations of whole-blood viscosity using Rheolog™-a new scanning capillary viscometer. Clin Chim Acta, 332, pp. 79-82.
14. Rosenson, RS and Wolff, D. (2004) Comparison of two whole-blood viscometers: Implications for cardiovascular and thrombosis research. Thromb Haemost, 92, pp. 225-226.
15. Lee, AJ, Mowbray, PI, Lowe, GD, Rumley, A., Fowkes, FG and Allan, PL. (1998) Blood viscosity and elevated carotid intima-media thickness in men and women: The Edinburgh Artery Study. Circulation, 97, pp. 1497-1573.
16. Lowe, GDO, Lee, AJ, Rumley, A., Price, JF and Fowkes, FG. (1997) Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. Br J Haematol, 96, pp. 168-173.
17. Coull, BM, Beamer, N., de Garmo, P., Sexton, G., Nordt, F., Knox, R. and Seaman, GV. (1991) Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke, 22, pp. 162-168.
18. Resch, KL, Ernst, E., Matrai, A. and Paulsen, HF. (1992) Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med, 117, pp. 371-375.
19. Bozzo, J., Escolar, G., Hernandez, MR, Galan, AM and Ordinas, A. (2001) Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability. J Cardiovasc Pharmacol, 38, pp. 183-190.
20. Strano, A., Davi, G., Avellone, G., Novo, S. and Pinto, A. (1984) Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology, 35, pp. 439-446.
21. Stormer, B., Kleinschmidt, K., Loose, D. and Kremer, K. (1977) Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs. Curr Med Res Opin, 4, pp. 588-595.
22. Dawson, DL, Zheng, Q., Worthy, SA, Charles, B. and Bradley, DVJr. (2002) Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication. Angiology, 53, pp. 509-520.
23. Rosenson, RS, Wolff, D., Green, D., Boss, AH and Kensey, KR. (2004) Aspirin does not alter native blood viscosity. J Thromb Haemost, 2, pp. 340-341.
24. Akhtar, M., Ordovas, K., Martin, A., Higgins, CB and Michaels, AD. (2007) Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy. Congest Heart Fail, 13, pp. 130-135.
25. Rosenson, RS. (1993) Viscosity and ischemic heart disease. J Vasc Med Biol, 4, pp. 206-212.